AMSF Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
AMSF is not a good buy right now for a beginner long-term investor with $50,000-$100,000 who wants to act immediately. The stock has neutral-to-bearish technicals, no strong proprietary buy signal, and recent analyst revisions show falling price targets after earnings misses. Long-term fundamentals are still acceptable because revenue grew in the latest quarter, but earnings declined, so the stock looks more like a hold than an outright buy at this time.
Current price is 30.3, essentially flat on the day, with the market closed. Trend indicators are weak: MACD histogram is -0.113 and still below zero, RSI_6 is 44.5, which is neutral, and moving averages are bearish with SMA_200 > SMA_20 > SMA_5. That structure points to a downward or sideways trend rather than a confirmed uptrend. Key levels are Pivot 30.598, resistance at 31.588 and 32.199, and support at 29.609 and 28.998. The stock is sitting below the pivot, which reinforces a cautious stance.
Revenue in Q1 2026 increased 7.91% year over year to 81.74 million, which shows the business is still growing top line. Analyst commentary also notes the CEO's confidence in sustaining top-line growth, and Citizens remains Outperform despite cutting its target. The options open-interest put-call ratio is also mildly bullish.
There is no recent positive news catalyst, no recent insider buying trend, no notable hedge fund accumulation, and no recent congress trading data. The stock also lacks Intellectia buy signals today.
In Q1 2026, Amerisafe posted revenue of 81.743 million, up 7.91% year over year, which is the latest quarter season available. However, net income dropped to 8.145 million, down 8.98% YoY, and EPS fell to 0.43, down 8.51% YoY. This indicates sales growth without corresponding profit growth, which is weaker for a long-term buy case.
Recent analyst trend is negative: Truist cut its target from 45 to 36 in February and then to 34 in April, maintaining Hold after the Q1 earnings miss. Citizens also lowered its target from 50 to 45, though it kept Outperform. Overall Wall Street view is mixed but leaning cautious: there is some optimism about pricing and top-line growth, but the dominant message is reduced targets and concerns about valuation, casualty reserves, and industry pressure.
